Leadership

The pharmacy benefits system wasn't just outdated — it was misaligned by design. PBMs profit from spread pricing, rebate retention, and opaque formularies. The more a drug costs, the more they make. Employers and patients bear the consequences.

We saw this firsthand — working directly with brokers, TPAs, and self-funded employer groups through PBM evaluations and RFP processes. The same story played out every time: employers wanted lower costs, but their PBM's business model depended on higher ones.

RxDune was built to replace that model entirely. One platform that routes every prescription to the lowest-cost clinically appropriate channel, in real time, with full transparency and a flat admin fee. No hidden incentives. No conflicts of interest. Just aligned economics.